Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
NEW YORK, Jan. 9, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
Summary
GlobalData's new report, "Facial Aesthetics (Botulinum Toxin, Dermal Fillers) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018" provides key data, information and analysis on the global facial aesthetics market. It gives the market landscape, competitive landscape and market trends information for the facial aesthetics market, and provides comprehensive information on the key trends affecting the market, as well as key analytical content. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- The key geographies covered are the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Botulinum Toxin (Botox) and Dermal Fillers (HA fillers and Other Dermal Fillers).
- Annualized market revenue data for 2011 and forecast forward to 2018, as well as company shares data for 2011. Company shares data for Botox and Dermal Fillers for 2011 are also provided.
- Qualitative analysis of key market trends, market drivers, and restraints within the facial aesthetics market.
- Information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- The key players covered are Allergan, Q-Med, Mentor, Medicis and Merz.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the facial aesthetics market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What's the next big thing in the facial aesthetics market landscape? Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global facial aesthetics market and the factors shaping it.
1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 GlobalData Report Guidance 7
3 Facial Aesthetics - Device Overview 8
3.1 Botulinum Toxin 8
3.2 Dermal Fillers 8
3.2.1 Hyaluronic Acid Based Dermal Fillers 8
3.2.2 Other Dermal Fillers 9
4 Facial Aesthetics - Global Market Characterization 10
4.1 Facial Aesthetics Market, Global, Revenue ($bn), Forecast, 2011-2018 10
4.2 Facial Aesthetics Market, Key Trends 11
4.2.1 Hyaluronic Acid Based Dermal Fillers to Drive the Market for Facial Aesthetics in the Future 11
4.2.2 Inception of Hyaluronic Acid Based Dermal Fillers has led to the Decline of Collagen Products 11
4.3 Facial Aesthetics, Market Dynamics 12
4.3.1 Market Drivers 13
4.3.2 Market Restraints 14
5 Facial Aesthetics Market - Segment Analysis 16
5.1 Botulinum Toxin, Global, Revenue ($bn), Forecast, 2011–2018 16
5.2 Botulinum Toxin, Market Dynamics 17
5.2.1 Key Market Drivers: Increasing Number of Procedures and Reducing Price Trend 17
5.2.2 Market Growth Restraints: High Side Effects Profile and Temporary Results of Botulinum Toxin 18
5.3 Dermal Fillers, Global, Revenue ($m), Forecast, 2011–2018 19
5.4 Dermal Fillers, Market Dynamics 20
5.4.1 Market Drivers 20
5.4.2 Market Restraint 21
6 Facial Aesthetics Market, by Country, 2011–2018 22
6.1 Facial Aesthetics Market, the US, Revenue ($m), Forecast, 2011–2018 22
6.2 Facial Aesthetics Market, Canada, Revenue ($m), Forecast, 2011–2018 24
6.3 Facial Aesthetics Market, the UK, Revenue ($m), Forecast, 2011–2018 26
6.4 Facial Aesthetics Market, Germany, Revenue ($m), Forecast, 2011–2018 28
6.5 Facial Aesthetics Market, France, Revenue ($m), Forecast, 2011–2018 30
6.6 Facial Aesthetics Market, Italy, Revenue ($m), Forecast, 2011–2018 32
6.7 Facial Aesthetics Market, Spain, Revenue ($m), Forecast, 2011–2018 34
6.8 Facial Aesthetics Market, Japan, Revenue ($m), Forecast, 2011–2018 36
6.9 Facial Aesthetics Market, China, Revenue ($m), Forecast, 2011–2018 38
6.10 Facial Aesthetics Market, India, Revenue ($m), Forecast, 2011–2018 40
6.11 Facial Aesthetics Market, Australia, Revenue ($m), Forecast, 2011–2018 42
6.12 Facial Aesthetics Market, Brazil, Revenue ($m), Forecast, 2011–2018 44
7 Global Facial Aesthetics Market - Strategic Competitive Assessment 46
7.1 Facial Aesthetics Market, Global, Company Share (%), 2011 46
7.2 Botulinum Toxin Market, Global, Company Share (%), 2011 47
7.3 Dermal Fillers Market, Global, Company Share (%), 2011 48
7.4 Facial Aesthetics, Market Opportunities and Risk Evaluation 50
7.4.1 Opportunities 50
7.4.2 Risks 51
7.5 Facial Aesthetics Market, Key Market Participants 51
7.5.1 Allergan, Inc 51
7.5.2 Q-Med AB (Subsidiary of Galderma S.A.) 54
7.5.3 Medicis Pharmaceuticals Corporation 59
7.5.4 Merz GmbH & Co. KGaA 60
8 Facial Aesthetics Market – Strategic Pipeline Assessment 64
8.1 Dermal Fillers Market, List of Pipeline Products, Global, 2011 64
8.2 Profiles of Pipeline Products in Facial Aesthetics Market 65
8.2.1 Aeon Astron Corporation: Aeon Dermal Filler 65
8.2.2 Contura International A/S: Aquamid 65
8.2.3 Merz Pharma GmbH & Co. KgaA: Belotero Soft 65
8.2.4 Mosaic Medical Technologies, Inc: Dermal Filler 66
8.2.5 Allergan, Inc.: Juvederm Voluma 66
8.2.6 Q-Med AB: Macrolane 66
8.2.7 Q-Med AB: Restylane Touch 67
8.2.8 EternoGen, LLC: Aesthetic Procedures 67
8.2.9 Anika Therapeutics, Inc.: Next Generation Elevess Dermal Filler 67
8.2.10 FibroGen, Inc. FG-5030 68
8.2.11 Prollenium Medical Technologies, Inc: Revanesse Ultra 68
8.2.12 TEI Biosciences Inc.: Injectable Dermal Fille 68
8.2.13 Mentor Worldwide LLC: Puragen 69
8.2.14 Mentor Worldwide LLC: Puragen Plus 69
8.2.15 Teoxane laboratories: Teosyal Deep Lines 69
8.2.16 Teoxane laboratories: Teosyal First Lines 70
8.2.17 Teoxane laboratories: Teosyal Global Action 70
8.2.18 Teoxane laboratories: Teosyal Kiss 70
8.2.19 Teoxane laboratories: Teosyal Meso 71
8.2.20 Teoxane laboratories: Teosyal Touch Up 71
8.2.21 Teoxane laboratories: Teosyal Ultra Deep 71
8.3 Botulinum Toxin Market, List of Pipeline Products, Global, 2011 72
8.3.1 Revance Therapeutics, Inc.: RT001 72
8.3.2 Q-Med AB: Azzalure 72
8.3.3 Johnson & Johnson: PurTox 73
9 Appendix 74
9.1 Definitions 74
9.1.1 Facial Aesthetics 74
9.2 Acronyms 75
9.3 Sources 75
9.4 Research Methodology 76
9.5 Secondary Research 76
9.6 Primary Research 77
9.7 Models 77
9.8 Forecasts 77
9.9 Expert Panels 78
9.10 GlobalData Consulting 78
9.11 Contact Us 78
9.12 Disclaimer 78
List of Tables
Table 1: Facial Aesthetics Market, Global, Revenue ($bn), 2011–2018 10
Table 2: Collagen Products, The US, Number of Procedures (000's), 2000–2011 11
Table 3: Botulinum Toxin, Global, Revenue ($bn), 2011–2018 16
Table 4: Botulinum Toxin Market, The US, Number of Botulinum Toxin Procedures (million), 2000–2011 17
Table 5: Dermal Fillers, Global, Revenue ($m), 2011–2018 19
Table 6: Dermal Fillers Market, The US, Number of Procedures (million), 2000–2011 20
Table 7: Facial Aesthetics Market, the US, Revenue ($m), 2011–2018 22
Table 8: Facial Aesthetics Market, the US, Procedures (million), 2011 23
Table 9: Facial Aesthetics Market, Canada, Revenue ($m), 2011–2018 24
Table 10: Facial Aesthetics Market, Canada, Procedures (000's), 2011 25
Table 11: Facial Aesthetics Market, the UK, Revenue ($m), 2011–2018 26
Table 12: Facial Aesthetics Market, the UK, Procedures (000's), 2011 27
Table 13: Facial Aesthetics Market, Germany, Revenue ($m), 2011–2018 28
Table 14: Facial Aesthetics Market, Germany, Procedures (000's), 2011 29
Table 15: Facial Aesthetics Market, France, Revenue ($m), 2011–2018 30
Table 16: Facial Aesthetics Market, France, Procedures (000's), 2011 31
Table 17: Facial Aesthetics Market, Italy, Revenue ($m), 2011–2018 32
Table 18: Facial Aesthetics Market, Italy, Procedures (000's), 2011 33
Table 19: Facial Aesthetics Market, Spain, Revenue ($m), 2011–2018 34
Table 20: Facial Aesthetics Market, Spain, Procedures (000's), 2011 35
Table 21: Facial Aesthetics Market, Japan, Revenue ($m), 2011–2018 36
Table 22: Facial Aesthetics Market, Japan, Procedures (000's), 2011 37
Table 23: Facial Aesthetics Market, China, Revenue ($m), 2011–2018 38
Table 24: Facial Aesthetics Market, China, Procedures (000's), 2011 39
Table 25: Facial Aesthetics Market, India, Revenue ($m), 2011–2018 40
Table 26: Facial Aesthetics Market, India, Procedures (000's), 2011 41
Table 27: Facial Aesthetics Market, Australia, Revenue ($m), 2011–2018 42
Table 28: Facial Aesthetics Market, Australia, Procedures (000's), 2011 43
Table 29: Facial Aesthetics Market, Brazil, Revenue ($m), 2011–2018 44
Table 30: Facial Aesthetics Market, Brazil, Procedures (000's), 2011 45
Table 31: Facial Aesthetics Market, Global, Revenue by Company ($m), 2011 46
Table 32: Botulinum Toxin Market, Global, Revenue by Company ($m), 2011 47
Table 33: Dermal Fillers Market, Global, Revenue by Company ($m), 2011 48
Table 34: Allergan, Key Marketed Products, Applications, Features and Benefits, 2012 52
Table 35: Safety and Effectiveness of Juvederm Injectable Gel with Lidocaine 52
Table 36: Allergan Inc., Acquires Groupe Corneal Laboratories SA, 2007 53
Table 37: Q-Med AB, Key Marketed Products, Applications, Features and Benefits, 2012 54
Table 38: Galderma Acquires Q–Med AB, 2011 55
Table 39: Mentor Worldwide, Key Marketed Products, Applications, Features and Benefits, 2012 57
Table 40: Reduced Pain With Use Of Proprietary Hyaluronic Acid With Lidocaine For Correction Of Nasolabial Folds: A Patient-Blinded, Prospective, Randomized Controlled Trial 57
Table 41: Johnson & Johnson Acquires Mentor Corporation, 2009 57
Table 42: Medicis, Key Marketed Products, Applications, Features and Benefits, 2011 59
Table 43: Merz GmbH & Co. KGaA, Key Marketed Products, Applications, Features and Benefits, 2012 61
Table 44: Evaluation of Pain With the Use of Lidocaine-Mixed Radiesse Injectable Dermal Filler for the Treatment of Nasolabial Folds 61
Table 45: Merz Pharma Completes The Acquisition of BioForm Medical, 2010 62
Table 46: Dermal Fillers Market, List of Pipeline Products, Global, 2011 64
Table 47: Aeon Dermal Filler, Product Status 65
Table 48: Aquamid, Product Status 65
Table 49: Belotero Soft, Product Status 65
Table 50: Dermal Filler, Product Status 66
Table 51: Juvederm Voluma, Product Status 66
Table 52: Macrolane, Product Status 66
Table 53: Restylane Touch, Product Status 67
Table 54: Dermal Filler - Aesthetic Procedures, Product Status 67
Table 55: Next Generation Elevess Dermal Filler, Product Status 67
Table 56: FG-5030, Product Status 68
Table 57: Revanesse Ultra, Product Status 68
Table 58: Injectable Dermal Filler, Product Status 68
Table 59: Puragen, Product Status 69
Table 60: Puragen Plus, Product Status 69
Table 61: Teosyal Deep Lines, Product Status 69
Table 62: Teosyal First Lines, Product Status 70
Table 63: Teosyal Global Action, Product Status 70
Table 64: Teosyal Kiss, Product Status 70
Table 65: Teosyal Meso, Product Status 71
Table 66: Teosyal Touch Up, Product Status 71
Table 67: Teosyal Ultra Deep, Product Status 71
Table 68: Botulinum Toxin Market, List of Pipeline Products, Global, 2011 72
Table 69: RT001, Product Status 72
Table 70: Azzalure, Product Status 72
Table 71: PurTox, Product Status 73
List of Figures
Figure 1: Facial Aesthetics Market, Market Segmentation, 2012 8
Figure 2: Facial Aesthetics Market, Global, Revenue ($bn), 2011–2018 10
Figure 3: Collagen Products, The US, Number of Procedures (000's), 2000–2011 11
Figure 4: Facial Aesthetics, Market Dynamics 12
Figure 5: Botulinum Toxin, Global, Revenue ($bn), 2011–2018 16
Figure 6: Botulinum Toxin Market, The US, Number of Botulinum Toxin Procedures (million), 2000–2011 17
Figure 7: Dermal Fillers, Global, Revenue ($m), 2011–2018 19
Figure 8: Dermal Fillers Market, The US, Number of Procedures (million), 2000–2011 20
Figure 9: Facial Aesthetics Market, the US, Revenue ($m), 2011–2018 22
Figure 10: Facial Aesthetics Market, the US, Procedures (million), 2011 23
Figure 11: Facial Aesthetics Market, Canada, Revenue ($m), 2011–2018 24
Figure 12: Facial Aesthetics Market, Canada, Procedures (000's), 2011 25
Figure 13: Facial Aesthetics Market, the UK, Revenue ($m), 2011–2018 26
Figure 14: Facial Aesthetics Market, the UK, Procedures (000's), 2011 27
Figure 15: Facial Aesthetics Market, Germany, Revenue ($m), 2011–2018 28
Figure 16: Facial Aesthetics Market, Germany, Procedures (000's), 2011 29
Figure 17: Facial Aesthetics Market, France, Revenue ($m), 2011–2018 30
Figure 18: Facial Aesthetics Market, France, Procedures (000's), 2011 31
Figure 19: Facial Aesthetics Market, Italy, Revenue ($m), 2011–2018 32
Figure 20: Facial Aesthetics Market, Italy, Procedures (000's), 2011 33
Figure 21: Facial Aesthetics Market, Spain, Revenue ($m), 2011–2018 34
Figure 22: Facial Aesthetics Market, Spain, Procedures (000's), 2011 35
Figure 23: Facial Aesthetics Market, Japan, Revenue ($m), 2011–2018 36
Figure 24: Facial Aesthetics Market, Japan, Procedures (000's), 2011 37
Figure 25: Facial Aesthetics Market, China, Revenue ($m), 2011–2018 38
Figure 26: Facial Aesthetics Market, China, Procedures (000's), 2011 39
Figure 27: Facial Aesthetics Market, India, Revenue ($m), 2011–2018 40
Figure 28: Facial Aesthetics Market, India, Procedures (000's), 2011 41
Figure 29: Facial Aesthetics Market, Australia, Revenue ($m), 2011–2018 42
Figure 30: Facial Aesthetics Market, Australia, Procedures (000's), 2011 43
Figure 31: Facial Aesthetics Market, Brazil, Revenue ($m), 2011–2018 44
Figure 32: Facial Aesthetics Market, Brazil, Procedures (000's), 2011 45
Figure 33: Facial Aesthetics Market, Global, Company Share (%), 2011 46
Figure 34: Botulinum Toxin Market, Global, Company Share (%), 2011 47
Figure 35: Dermal Fillers Market, Global, Company Share (%), 2011 48
Figure 36: Botulinum Toxin Product Benchmarking 49
Figure 37: Hyaluronic Acid Based Dermal Fillers Product Benchmarking 49
Figure 38: Facial Aesthetics, Market Opportunities and Risk Evaluation, 2011 50
Figure 39: Allergan Inc., Internal Factor Analysis, 2012 53
Figure 40: Q-Med AB, Internal Factor Analysis, 2012 55
Figure 41: Mentor Worldwide, Internal Factor Analysis, 2012 58
Figure 42: Medicis Pharmaceutical Corporation, Internal Factor Analysis, 2012 60
Figure 43: Merz GmbH & Co. KGaA, Internal Factor Analysis, 2012 62
Companies mentioned
Allergan, Inc
Q-Med AB (Subsidiary of Galderma S.A.)
Mentor Worldwide LLC (Subsidiary of Ethicon, Inc.)
Medicis Pharmaceuticals Corporation
Merz GmbH & Co. KGaA
To order this report:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article